Mandiri Herindo Adiperkasa Tbk. vs Merck Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp141 (market cap 2.33T, 2.7M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is the larger of the two by market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (2.7M versus 37.6K). Which is the better fit depends on your goals.
| MAHA | MERK | |
|---|---|---|
Market Cap | 2.33T | 1.7T |
Volume | 2.7M | 37.6K |
Lot | 27K | 376 |
Turnover | 378.94M | 144.47M |
Average Price | 140.36 | 3,842.23 |
Value | 378.94M | 144.47M |
Indicative Equilibrium Price | 142 | 3,840 |
Indicative Equilibrium Volume | 20 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →